Breaking News Instant updates and real-time market news.

NUAN

Nuance

$17.02

0.02 (0.12%)

17:24
08/08/17
08/08
17:24
08/08/17
17:24

Nuance sees Q4 adjusted pro forma EPS 26c-31c, consensus 25c

Sees Q4 pro forma revenue $508M-$528M, consenus $500.93M.

  • 08

    Aug

  • 08

    Aug

NUAN Nuance
$17.02

0.02 (0.12%)

11/18/16
RAJA
11/18/16
UPGRADE
RAJA
Strong Buy
Nuance upgraded to Strong Buy from Outperform at Raymond James
01/06/17
LEHM
01/06/17
UPGRADE
Target $19
LEHM
Overweight
Nuance upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Saket Kalia upgraded Nuance Communications to Overweight calling the company a turnaround pick for 2017. The analyst sees limited downside from current share levels and sees 2017 as the revenue growth. Kalia raised his price target for the shares to $19 from $17.
06/12/17
DBAB
06/12/17
NO CHANGE
Target $25
DBAB
Buy
Nuance's new products double addressable market, says Deutsche Bank
Deutsche Bank analyst Nandan Amladi believes Nuance's new healthcare products "significantly expand" the company's market opportunity. New software that uses clinical language understanding techniques on transcribed notes to ensure that the documentation is complete doubles Nuance's market opportunity to about $5B, Amladi tells investors in a research note. He reiterates a Buy rating on the shares with a $25 price target.
06/29/17
CHLM
06/29/17
NO CHANGE
Target $24
CHLM
Buy
Nuance growth engine in healthcare not affected by hack, says Craig-Hallum
Craig-Hallum analyst Jeff Van Rhee noted that Nuance has been impacted by the "NotPetya" ransomware attack, though "very importantly" the hack doesn't appear to have affected Dragon Cloud services, which he identifies as the company's critical growth engine within healthcare. In fact, the opening of this platform for legacy transcription customers who have been impacted by the hack may accelerate their migration to Dragon Cloud, Van Rhee tells investors. While potential lost revenue from legacy transcription is meaningful, the analyst sees reputational risk as the larger issue and views it as "noteworthy" that the Dragon product has remained online. He keeps a Buy rating and $24 price target on Nuance shares.

TODAY'S FREE FLY STORIES

VSAT

ViaSat

$65.44

-0.01 (-0.02%)

08:03
12/11/18
12/11
08:03
12/11/18
08:03
Hot Stocks
ViaSat announces agreement with Sandler Partners »

Viasat announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 13

    Dec

MYE

Myers Industries

$15.83

-0.41 (-2.52%)

08:03
12/11/18
12/11
08:03
12/11/18
08:03
Hot Stocks
Myers Industries promotes Kevin Brackman to CFO »

Myers Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ASB

Associated Banc-Corp

$21.23

-0.4 (-1.85%)

08:03
12/11/18
12/11
08:03
12/11/18
08:03
Hot Stocks
Associated Banc-Corp subsidiary to acquire branch of Huntington Bancshares »

Associated Banc-Corp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSE

Trinseo

$47.00

0.61 (1.31%)

08:02
12/11/18
12/11
08:02
12/11/18
08:02
Hot Stocks
Trinseo CEO Chris Pappas to retire in 2019 »

Trinseo announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFX

Equifax

$98.46

-1.11 (-1.11%)

08:02
12/11/18
12/11
08:02
12/11/18
08:02
Hot Stocks
Equifax awarded utility patent for innovative NeuroDecision Technology »

Equifax has received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

SFIX

Stitch Fix

$25.92

-0.42 (-1.59%)

08:02
12/11/18
12/11
08:02
12/11/18
08:02
Recommendations
Stitch Fix analyst commentary  »

Stitch Fix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGM

LogMeln

$86.34

-0.55 (-0.63%)

07:59
12/11/18
12/11
07:59
12/11/18
07:59
Conference/Events
LogMeln management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

FTSI

FTS International

$7.36

-0.41 (-5.28%)

07:59
12/11/18
12/11
07:59
12/11/18
07:59
Upgrade
FTS International rating change  »

FTS International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URBN

Urban Outfitters

$37.70

0.7 (1.89%)

07:58
12/11/18
12/11
07:58
12/11/18
07:58
Hot Stocks
Urban Outfitters says retail comps up mid single-digit thus far in Q4 »

Urban Outfitters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LC

LendingClub

$2.94

-0.04 (-1.34%)

07:56
12/11/18
12/11
07:56
12/11/18
07:56
Conference/Events
LendingClub management to meet with Craig Hallum »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

HP

Helmerich & Payne

$59.22

-1.54 (-2.53%)

07:56
12/11/18
12/11
07:56
12/11/18
07:56
Upgrade
Helmerich & Payne rating change  »

Helmerich & Payne…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFIX

Stitch Fix

$25.92

-0.42 (-1.59%)

07:55
12/11/18
12/11
07:55
12/11/18
07:55
Recommendations
Stitch Fix analyst commentary  »

Stitch Fix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVTY

Tivity Health

$27.66

-12.94 (-31.87%)

, NTRI

Nutrisystem

$43.68

9.49 (27.76%)

07:55
12/11/18
12/11
07:55
12/11/18
07:55
Recommendations
Tivity Health, Nutrisystem analyst commentary  »

Tivity Health price…

TVTY

Tivity Health

$27.66

-12.94 (-31.87%)

NTRI

Nutrisystem

$43.68

9.49 (27.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

07:55
12/11/18
12/11
07:55
12/11/18
07:55
Initiation
Roche initiated  »

Roche assumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 13

    Dec

  • 24

    Dec

  • 18

    Mar

07:55
12/11/18
12/11
07:55
12/11/18
07:55
General news
U.S. chain store sales rebounded 2.1% in the week ended December 8 »

U.S. chain store sales…

AJG

Arthur J. Gallagher

$74.58

-0.03 (-0.04%)

07:55
12/11/18
12/11
07:55
12/11/18
07:55
Conference/Events
Arthur J. Gallagher to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

BLRX

BioLineRx

$0.66

0.005 (0.76%)

07:55
12/11/18
12/11
07:55
12/11/18
07:55
Conference/Events
BioLineRx to host investor meeting »

Investor Breakfast…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

THS

TreeHouse

$48.95

-1.22 (-2.43%)

07:55
12/11/18
12/11
07:55
12/11/18
07:55
Conference/Events
TreeHouse to host investor day »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

NVO

Novo Nordisk

$45.97

0.59 (1.30%)

07:54
12/11/18
12/11
07:54
12/11/18
07:54
Initiation
Novo Nordisk initiated  »

Novo Nordisk assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$86.94

-0.22 (-0.25%)

07:53
12/11/18
12/11
07:53
12/11/18
07:53
Initiation
Novartis initiated  »

Novartis assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$145.31

-0.07 (-0.05%)

07:53
12/11/18
12/11
07:53
12/11/18
07:53
Conference/Events
Johnson & Johnson management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

WFT

Weatherford

$0.46

-0.0579 (-11.21%)

07:53
12/11/18
12/11
07:53
12/11/18
07:53
Downgrade
Weatherford rating change  »

Weatherford downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$37.68

0.4 (1.07%)

07:52
12/11/18
12/11
07:52
12/11/18
07:52
Initiation
GlaxoSmithKline initiated  »

GlaxoSmithKline assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$38.41

0.23 (0.60%)

07:52
12/11/18
12/11
07:52
12/11/18
07:52
Initiation
AstraZeneca initiated  »

AstraZeneca assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNSA

Kiniksa

$25.04

3.59 (16.74%)

07:50
12/11/18
12/11
07:50
12/11/18
07:50
Hot Stocks
Kiniksa announces interim data of rilonacept trial, initiates RHAPSODY trial »

Kiniksa announced interim…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.